In particular, while a subset of HPV-negative HNSCC, primarily laryngeal carcinoma with NSD1 loss-of-function mutations, has a favorable prognosis [9], this represents only a minority of HNSCC, while >80% HPV-negative head and neck tumors are NSD1-wild type. The gene discussed is NSD1; the disease is laryngeal carcinoma.